Cargando…
Impact of tumour burden on chemotherapy-induced nausea and vomiting.
We investigated how residual tumour burden after cytoreductive surgery was related to the occurrence of acute and delayed nausea and vomiting in 101 ovarian cancer patients receiving their first chemotherapy course. The anti-emetic treatment included ondansetron combined with dexamethasone or placeb...
Autores principales: | Hursti, T. J., Avall-Lundqvist, E., Börjeson, S., Fredrikson, M., Fürst, C. J., Steineck, G., Peterson, C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2077107/ https://www.ncbi.nlm.nih.gov/pubmed/8855984 |
Ejemplares similares
-
Nausea in cancer chemotherapy is inversely related to urinary cortisol excretion.
por: Fredrikson, M., et al.
Publicado: (1992) -
Delayed chemotherapy-induced nausea is augmented by high levels of endogenous noradrenaline.
por: Fredrikson, M., et al.
Publicado: (1994) -
Endogenous cortisol exerts antiemetic effect similar to that of exogenous corticosteroids.
por: Hursti, T. J., et al.
Publicado: (1993) -
GIP receptor agonism blocks chemotherapy-induced nausea and vomiting
por: Borner, Tito, et al.
Publicado: (2023) -
Chemotherapy-Induced Nausea and Vomiting
por: Rapoport, Bernardo Leon, et al.
Publicado: (2015)